Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials.

R G LangleyApril W ArmstrongM G LebwohlAndrew BlauveltS HsuS TyringS RastogiR PillaiR Israel

Published in: The British journal of dermatology (2018)

Among patients who experienced inadequate responses to ustekinumab, rescue with brodalumab improved skin clearance outcomes compared with continuing ustekinumab.

Keyphrases

phase iii
open label
double blind
clinical trial
placebo controlled
phase ii
soft tissue
study protocol
wound healing
medical education
insulin resistance
weight loss
glycemic control
hidradenitis suppurativa